{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:46:55Z","timestamp":1761101215799},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:00:00Z","timestamp":1407369600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102793","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T18:41:31Z","timestamp":1407436891000},"page":"e102793","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Loss of Cytotoxicity and Gain of Cytokine Production in Murine Tumor-Activated NK Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"J\u00fcrgen R.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"R Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"LL Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"JC Sun","year":"2009","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"L Chiossone","year":"2009","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.176.3.1517","article-title":"CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity","volume":"176","author":"Y Hayakawa","year":"2006","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000237321","article-title":"Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations","volume":"110","author":"P Sedlmayr","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.161.1.400","article-title":"Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets","volume":"161","author":"M Frey","year":"1998","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"MA Cooper","year":"2001","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nri1088","article-title":"What does it take to make a natural killer?","volume":"3","author":"F Colucci","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","article-title":"Human natural killer cell development","volume":"214","author":"AG Freud","year":"2006","journal-title":"Immunol Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"JP Di Santo","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2006.00454.x","article-title":"Functional subsets of mouse natural killer cells","volume":"214","author":"Y Hayakawa","year":"2006","journal-title":"Immunol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"SS Farag","year":"2006","journal-title":"Blood Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.171.5.1527","article-title":"Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo","volume":"171","author":"A Nagler","year":"1990","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.172.3.1333","article-title":"NK cell compartments and their activation by dendritic cells","volume":"172","author":"G Ferlazzo","year":"2004","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nri886","article-title":"Natural killer cells and pregnancy","volume":"2","author":"A Moffett-King","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"B Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","article-title":"Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta","volume":"28","author":"M Saraste","year":"2007","journal-title":"Neurol Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"N Anfossi","year":"2006","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2004-08-3156","article-title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","volume":"105","author":"NC Fernandez","year":"2005","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"S Kim","year":"2005","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.172.1.88","article-title":"The IL-12 signature: NK cell terminal CD56+high stage and effector functions","volume":"172","author":"MJ Loza","year":"2004","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"N Dalbeth","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.173.10.6418","article-title":"CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation","volume":"173","author":"N Dalbeth","year":"2004","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1084\/jem.167.2.452","article-title":"Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells","volume":"167","author":"I Anegon","year":"1988","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(00)80257-5","article-title":"Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)","volume":"5","author":"BJ Chambers","year":"1996","journal-title":"Immunity"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1034\/j.1600-0528.2002.017407.x","article-title":"Innate defenses in the liver during Listeria infection","volume":"174","author":"LP Cousens","year":"2000","journal-title":"Immunol Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.180.4.2099","article-title":"Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+\/CD44high T cells and its antitumor action","volume":"180","author":"S Dubois","year":"2008","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1073\/pnas.0600240103","article-title":"Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}","volume":"103","author":"MP Rubinstein","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20122571","article-title":"IL-2-dependent adaptive control of NK cell homeostasis","volume":"210","author":"G Gasteiger","year":"2013","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.143.10.3183","article-title":"Comparative studies of human FcRIII-positive and negative natural killer cells","volume":"143","author":"A Nagler","year":"1989","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ni1197","article-title":"Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma","volume":"6","author":"Y Laouar","year":"2005","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/bcmd.2002.0506","article-title":"The \u201cex vivo\u201d patterns of CD2\/CD7, CD57\/CD11c, CD38\/CD11b, CD45RA\/CD45RO, and CD11a\/HLA-DR expression identify acute\/early and chronic\/late NK-cell activation states","volume":"28","author":"M Lima","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ijc.2910530524","article-title":"Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures","volume":"53","author":"A Maenpaa","year":"1993","journal-title":"Int J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.177.8.5659","article-title":"Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis","volume":"177","author":"T Aranami","year":"2006","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"MA Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"F Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"DM Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"JP Lodolce","year":"1998","journal-title":"Immunity"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"MK Kennedy","year":"2000","journal-title":"J Exp Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.0503360102","article-title":"Survival adjustment of mature dendritic cells by IL-15","volume":"102","author":"SP Dubois","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","article-title":"Dendritic cells prime natural killer cells by trans-presenting interleukin 15","volume":"26","author":"M Lucas","year":"2007","journal-title":"Immunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"TA Fehniger","year":"1999","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/cimm.1998.1376","article-title":"Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody","volume":"189","author":"T Kunikata","year":"1998","journal-title":"Cell Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.4049\/jimmunol.136.12.4480","article-title":"The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes","volume":"136","author":"LL Lanier","year":"1986","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T19:57:50Z","timestamp":1689451070000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102793"}},"subtitle":[],"editor":[{"given":"Pranela","family":"Rameshwar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,7]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102793","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,7]]}}}